| FentanylLover vs Steve | 12–7 | 63.16% |
| FentanylLover vs Hwoarang | 12–3 | 80.00% |
| FentanylLover vs Jin | 9–5 | 64.29% |
| FentanylLover vs Law | 10–3 | 76.92% |
| FentanylLover vs King | 4–5 | 44.44% |
| FentanylLover vs Reina | 8–0 | 100.00% |
| FentanylLover vs Kazuya | 3–2 | 60.00% |
| FentanylLover vs Lee | 4–1 | 80.00% |
| FentanylLover vs Yoshimitsu | 2–2 | 50.00% |
| FentanylLover vs Alisa | 2–2 | 50.00% |
| FentanylLover vs Bryan | 1–2 | 33.33% |
| FentanylLover vs Jack-8 | 2–1 | 66.67% |
| FentanylLover vs Dragunov | 2–1 | 66.67% |
| FentanylLover vs Claudio | 2–1 | 66.67% |
| FentanylLover vs Miary Zo | 0–3 | 0.00% |
| FentanylLover vs Paul | 2–0 | 100.00% |
| FentanylLover vs Devil Jin | 1–1 | 50.00% |
| FentanylLover vs Lili | 2–0 | 100.00% |
| FentanylLover vs Lars | 0–2 | 0.00% |
| FentanylLover vs Leroy | 0–2 | 0.00% |
| FentanylLover vs Victor | 0–2 | 0.00% |
| FentanylLover vs Eddy | 0–2 | 0.00% |
| FentanylLover vs Heihachi | 0–2 | 0.00% |
| FentanylLover vs Fahkumram | 2–0 | 100.00% |
| FentanylLover vs Armor King | 1–1 | 50.00% |
| FentanylLover vs Asuka | 1–0 | 100.00% |
| FentanylLover vs Panda | 1–0 | 100.00% |
| FentanylLover vs Jun | 0–1 | 0.00% |
| FentanylLover vs Azucena | 1–0 | 100.00% |
| FentanylLover vs Lidia | 1–0 | 100.00% |
| FentanylLover vs Clive | 1–0 | 100.00% |
| FentanylLover vs Anna | 1–0 | 100.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.